BIOPHARMACEUTICAL 

 

Ligand Binding Assays: LBAs continue to be the primary tool used in the biopharmaceutical sciences to quantitate proteins and anti-drug antibodies in biological fluids and tissues. This assay platform is a useful tool used from early drug discovery, through pre-clinical toxicology work, and clinical studies.

 

LC-MS/MS: Combined with various sophisticated sample preparation techniques, LC-MS/MS is used to meet bioanalytical needs for drug discovery, preclinical, and clinical studies, including bioanalysis of drugs and metabolites, biomarkers, and active endogenous compounds in biological fluids and tissues.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PHARMACEUTICAL  

 

Discovery: In the discovery phase of the drug development pipeline, new drug molecular structures, delivery mechanisms, or simply ideas will be too many to see through every single one of them. The Discovery Group is focused on providing fast turnaround times to testing our clients’ research ideas.

 

LC-MS/MS: Combined with various sophisticated sample preparation techniques, LC-MS/MS is used to meet bioanalytical needs for drug discovery, preclinical, and clinical studies, including bioanalysis of drugs and metabolites, biomarkers, and active endogenous compounds in biological fluids and tissues.

BIOMARKERS  

 

Biomarkers are measurements of analytes in biological fluids and tissues that inform the investigator on the effect a drug has on a biological system and often are used to identify the correct patient subset to dose with a new therapeutic entity. KCAS has a large toolbox we can use to meet our clients’ biomarker needs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SAMPLE KITS  

 

KCAS can provide various types of supplies and instructions needed to guide Clinical Site personnel through the process of collecting various matrices/tissues as outlined within the protocol of their trial.